Cormorant Asset Management LP 13D and 13G filings for Corbus Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:09 pm Purchase | 2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Cormorant Asset Management LP | 2,375,000 19.500% | 350,000 (+17.28%) | Filing |
| 2024-03-18 4:11 pm Purchase | 2024-03-08 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Cormorant Asset Management LP | 2,025,000 19.300% | 2,025,000 (New Position) | Filing |